CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...

A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...

DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...

Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient ...

A study assessed the effects of intravascular volume expansion on deep pelvic vein size using the 200-150-125 rule for the ...

The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...

The 24-month outcomes from the VIVID clinical trial, which evaluated the safety and efficacy of the Duo venous stent system ...

Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the ...

The first clinical use of the Javelin peripheral intravascular lithotripsy (IVL) catheter (Shockwave Medical) for the treatment ...

Investigators from the LIFE-BTK randomized controlled trial evaluating the use of the Drug-Eluting Resorbable Scaffold (Abbott) ...